Itron, Inc. (NASDAQ:ITRI – Free Report) – Stock analysts at Zacks Research increased their FY2024 EPS estimates for Itron in a research note issued to investors on Tuesday, November 19th. Zacks Research analyst R. Department now forecasts that the scientific and technical instruments company will post earnings of $5.31 per share for the year, up from their prior forecast of $4.47. The consensus estimate for Itron’s current full-year earnings is $5.33 per share. Zacks Research also issued estimates for Itron’s Q1 2025 earnings at $1.07 EPS, Q2 2025 earnings at $1.08 EPS, Q4 2025 earnings at $1.09 EPS and FY2025 earnings at $4.43 EPS.
ITRI has been the subject of a number of other research reports. Stephens reissued an “equal weight” rating and set a $110.00 price target on shares of Itron in a research note on Monday, August 5th. Robert W. Baird increased their price objective on shares of Itron from $123.00 to $132.00 and gave the company an “outperform” rating in a research note on Friday, November 1st. Oppenheimer increased their price target on shares of Itron from $120.00 to $124.00 and gave the company an “outperform” rating in a research report on Friday, November 1st. Roth Mkm upped their target price on Itron from $125.00 to $130.00 and gave the company a “buy” rating in a research note on Friday, November 1st. Finally, Janney Montgomery Scott initiated coverage on Itron in a report on Friday, September 27th. They issued a “buy” rating and a $131.00 price target for the company. Four equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $123.92.
Itron Stock Up 2.2 %
Itron stock opened at $118.93 on Friday. The company has a market capitalization of $5.36 billion, a P/E ratio of 24.37, a PEG ratio of 0.87 and a beta of 1.46. Itron has a fifty-two week low of $65.42 and a fifty-two week high of $124.90. The stock has a 50-day simple moving average of $109.53 and a 200-day simple moving average of $105.02. The company has a debt-to-equity ratio of 0.91, a quick ratio of 2.83 and a current ratio of 3.36.
Itron (NASDAQ:ITRI – Get Free Report) last posted its quarterly earnings data on Thursday, October 31st. The scientific and technical instruments company reported $1.84 earnings per share for the quarter, topping analysts’ consensus estimates of $1.13 by $0.71. The business had revenue of $615.46 million for the quarter, compared to analyst estimates of $596.41 million. Itron had a return on equity of 19.03% and a net margin of 9.37%. The company’s revenue was up 9.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.98 earnings per share.
Institutional Investors Weigh In On Itron
Hedge funds and other institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. grew its stake in shares of Itron by 0.8% in the 1st quarter. Vanguard Group Inc. now owns 5,701,337 shares of the scientific and technical instruments company’s stock valued at $527,488,000 after purchasing an additional 45,909 shares during the period. Geode Capital Management LLC boosted its position in Itron by 0.5% in the third quarter. Geode Capital Management LLC now owns 1,074,940 shares of the scientific and technical instruments company’s stock valued at $114,835,000 after buying an additional 5,630 shares in the last quarter. Handelsbanken Fonder AB increased its holdings in shares of Itron by 62.7% during the third quarter. Handelsbanken Fonder AB now owns 899,789 shares of the scientific and technical instruments company’s stock worth $96,106,000 after buying an additional 346,615 shares in the last quarter. Select Equity Group L.P. raised its stake in shares of Itron by 86.2% in the second quarter. Select Equity Group L.P. now owns 603,877 shares of the scientific and technical instruments company’s stock valued at $59,760,000 after acquiring an additional 279,629 shares during the last quarter. Finally, Janus Henderson Group PLC boosted its holdings in shares of Itron by 2.2% in the 1st quarter. Janus Henderson Group PLC now owns 542,943 shares of the scientific and technical instruments company’s stock worth $50,233,000 after acquiring an additional 11,918 shares in the last quarter. Institutional investors and hedge funds own 96.19% of the company’s stock.
Insiders Place Their Bets
In other news, CFO Joan S. Hooper sold 509 shares of the firm’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $102.15, for a total transaction of $51,994.35. Following the transaction, the chief financial officer now owns 72,338 shares in the company, valued at approximately $7,389,326.70. This trade represents a 0.70 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Thomas Deitrich sold 37,500 shares of the stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $104.83, for a total transaction of $3,931,125.00. Following the transaction, the chief executive officer now directly owns 205,276 shares in the company, valued at $21,519,083.08. The trade was a 15.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 39,066 shares of company stock worth $4,092,737. Company insiders own 1.45% of the company’s stock.
About Itron
Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.
Featured Stories
- Five stocks we like better than Itron
- What Are Dividend Champions? How to Invest in the Champions
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
- Health Care Stocks Explained: Why You Might Want to Invest
- MarketBeat Week in Review – 11/18 – 11/22
- Investing in Travel Stocks Benefits
- 2 Finance Stocks With Competitive Advantages You Can’t Ignore
Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.